Skip to main content

Advertisement

SpringerLink
Log in

Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Goals of the work

To assess the relationship between oral mucositis (OM) and adverse clinical and economic outcomes in patients with hematologic malignancies receiving allogeneic hematopoietic stem-cell transplantation (HSCT).

Materials and methods

A retrospective chart review study of 281 allogeneic HSCT recipients with hematologic malignancies was undertaken at a single academic center. OM extent and severity were assessed across eight oropharyngeal sites using a validated scale, which was scored as follows: no erythema/ulceration=0; erythema only=I; ulceration, one site=II; ulceration, two sites=III; ulceration, three sites=IV and ulceration, four or more sites=V. OM assessments began on the day of conditioning and continued twice weekly within 28 days or hospital discharge. Analyses examined the relationship between the worst OM grade and selected adverse outcomes, including days with fever, days of total parenteral nutrition (TPN), days of parenteral narcotic therapy, incidence of significant (common terminology criteria (CTC) grade 3 or 4) infection, mortality and inpatient days and charges.

Main results

The mean age of the study subjects was 41 years. Of the patients, 96% (n = 269) received total body irradiation and 76% (n = 214) experienced an OM grade of ≥II (i.e., ulceration). The worst OM grade was significantly (p < 0.05) associated with the number of days of TPN and parenteral narcotic therapy, number of days with fever, incidence of significant infection, time in hospital and total inpatient charges.

Conclusions

OM is associated with worse clinical and economic outcomes in patients with hematologic malignancies undergoing allogeneic HSCT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Bellm LA, Epstein JB, Rose-Ped A et al (2000) Patient reports of complications of bone marrow transplantation. Support Care Cancer 8:33–39

    PubMed  CAS  Google Scholar 

  2. Cutler C, Li S, Kim HT et al (2005) Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens. Biol Blood Marrow Transplant 11(5):383–388

    Article  PubMed  CAS  Google Scholar 

  3. Elting LS, Cooksley C, Chambers M et al (2003) The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98:1531–1539

    Article  PubMed  Google Scholar 

  4. Hwang WYK, Koh L-P, Ng HJ et al (2004) A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 34:51–56

    Article  PubMed  CAS  Google Scholar 

  5. McGuire DB, Altomonte V, Peterson DE et al (1993) Patterns of mucositis and pain in patients receiving preparatory and bone marrow transplantation. Oncol Nurs Forum 20:1493–1502

    PubMed  CAS  Google Scholar 

  6. Monopoli M, Woo S, Valley M, Sonis S (1991) A site-based scoring system of chemotherapy-induced oral mucositis in bone marrow transplant recipients. Proceedings of the Annual Meeting of the Society for Oral Oncology (abstract)

  7. Rapoport AP, Miller Watelet LF, Linder T et al (1999) Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants. J Clin Oncol 17:2446–2453

    PubMed  CAS  Google Scholar 

  8. Robien K, Schubert MM, Bruemmer B et al (2004) Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol 22:1268–1275

    Article  PubMed  Google Scholar 

  9. Ruescher TJ, Sodeifi A, Scrivani SJ et al (1998) The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 82(11):2275–2281

    Article  PubMed  CAS  Google Scholar 

  10. Sonis ST, Oster G, Fuchs H et al (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19(8):2201–2205

    PubMed  CAS  Google Scholar 

  11. Spielberger R, Stiff P, Bensinger W et al (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351:2590–2598

    Article  PubMed  CAS  Google Scholar 

  12. Wardley AM, Jayson GC, Swindell R et al (2000) Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoeitic progenitor rescue. Br J Haematol 110:292–299

    Article  PubMed  CAS  Google Scholar 

  13. Woo SB, Sonis ST, Monopoli MM et al (1993) A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer 72:1612–1617

    Article  PubMed  CAS  Google Scholar 

  14. Zerbe MB, Parkerson SG, Ortlieb ML et al (1992) Relationships between oral mucositis and treatment variables in bone marrow transplant patients. Cancer Nurs 15:196–205

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

Financial support was provided by Amgen, Thousand Oaks, CA.

Author information

Authors and Affiliations

  1. Policy Analysis Incorporated (PAI), Four Davis Court, Brookline, MA, 02445, USA

    Montserrat Vera-Llonch & Gerry Oster

  2. Dana Farber Cancer Institute and Brigham and Women’s Hospital, 75 Francis Street, Boston, MA, USA

    Colleen M. Ford & Stephen Sonis

  3. Amgen Incorporated, One Amgen Center Drive, Thousand Oaks, CA, USA

    John Lu

Authors
  1. Montserrat Vera-Llonch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gerry Oster
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Colleen M. Ford
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stephen Sonis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gerry Oster.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vera-Llonch, M., Oster, G., Ford, C.M. et al. Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer 15, 491–496 (2007). https://doi.org/10.1007/s00520-006-0176-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-006-0176-9

Keywords

Search

Navigation